Aayush Kothari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Aayush Kothari has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Chet Oon
Department of Cell, Developmental, and Cancer Biology, Oregon Health and Science University, Portland, OR 1
1 shared publicationJason Link
Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR 2
1 shared publication- Mara H. Sherman
Cancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, USA
1 shared publication - Rosalie C. Sears
Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR, USA
1 shared publication Sohinee Bhattacharyya
Department of Cell, Developmental, and Cancer Biology, Oregon Health and Science University, Portland, OR 1
1 shared publicationWesley Horton
Department of Cell, Developmental, and Cancer Biology, Oregon Health and Science University, Portland, OR 1
1 shared publication
Latest Publications
- Open Access
- 20 May 2020
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 217 (8)
Acidic fibroblast growth factor underlies microenvironmental regulation of MYC in pancreatic cancer
Despite a critical role for MYC as an effector of oncogenic RAS, strategies to target MYC activity in RAS-driven cancers are lacking. In genetically engineered mouse models of lung and pancreatic cancer, oncogenic KRAS is insufficient to drive tumorigenesis, while addition of modest MYC overexpression drives robust tumor formation, suggesting that mechanisms beyond the RAS pathway play key roles in MYC regulation and RAS-driven tumorigenesis. Here we show that acidic fibroblast growth factor (FGF1) derived from cancer-associated fibroblasts (CAFs) cooperates with cancer cell–autonomous signals to increase MYC level, promoter occupancy, and activity. FGF1 is necessary and sufficient for paracrine regulation of MYC protein stability, signaling through AKT and GSK-3β to increase MYC half-life. Patient specimens reveal a strong correlation between stromal CAF content and MYC protein level in the neoplastic compartment, and identify CAFs as the specific source of FGF1 in the tumor microenvironment. Together, our findings demonstrate that MYC is coordinately regulated by cell-autonomous and microenvironmental signals, and establish CAF-derived FGF1 as a novel paracrine regulator of oncogenic transcription.
- 20 May 2020
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 217 (8)
Open AccessAcidic fibroblast growth factor underlies microenvironmental regulation of MYC in pancreatic cancer
Despite a critical role for MYC as an effector of oncogenic RAS, strategies to target MYC activity in RAS-driven cancers are lacking. In genetically engineered mouse models of lung and pancreatic cancer, oncogenic KRAS is insufficient to drive tumorigenesis, while addition of modest MYC overexpression drives robust tumor formation, suggesting that mechanisms beyond the RAS pathway play key roles in MYC regulation and RAS-driven tumorigenesis. Here we show that acidic fibroblast growth factor (FGF1) derived from cancer-associated fibroblasts (CAFs) cooperates with cancer cell–autonomous signals to increase MYC level, promoter occupancy, and activity. FGF1 is necessary and sufficient for paracrine regulation of MYC protein stability, signaling through AKT and GSK-3β to increase MYC half-life. Patient specimens reveal a strong correlation between stromal CAF content and MYC protein level in the neoplastic compartment, and identify CAFs as the specific source of FGF1 in the tumor microenvironment. Together, our findings demonstrate that MYC is coordinately regulated by cell-autonomous and microenvironmental signals, and establish CAF-derived FGF1 as a novel paracrine regulator of oncogenic transcription.